Asset Details
Do you wish to reserve the book?
The complex role of Wnt ligands in type 2 diabetes mellitus and related complications
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The complex role of Wnt ligands in type 2 diabetes mellitus and related complications
Do you wish to request the book?
The complex role of Wnt ligands in type 2 diabetes mellitus and related complications
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The complex role of Wnt ligands in type 2 diabetes mellitus and related complications
2021
Overview
Type 2 diabetes mellitus (T2DM) is one of the major chronic diseases, whose prevalence is increasing dramatically worldwide and can lead to a range of serious complications. Wnt ligands (Wnts) and their activating Wnt signalling pathways are closely involved in the regulation of various processes that are important for the occurrence and progression of T2DM and related complications. However, our understanding of their roles in these diseases is quite rudimentary due to the numerous family members of Wnts and conflicting effects via activating the canonical and/or non‐canonical Wnt signalling pathways. In this review, we summarize the current findings on the expression pattern and exact role of each human Wnt in T2DM and related complications, including Wnt1, Wnt2, Wnt2b, Wnt3, Wnt3a, Wnt4, Wnt5a, Wnt5b, Wnt6, Wnt7a, Wnt7b, Wnt8a, Wnt8b, Wnt9a, Wnt9b, Wnt10a, Wnt10b, Wnt11 and Wnt16. Moreover, the role of main antagonists (sFRPs and WIF‐1) and coreceptor (LRP6) of Wnts in T2DM and related complications and main challenges in designing Wnt‐based therapeutic approaches for these diseases are discussed. We hope a deep understanding of the mechanistic links between Wnt signalling pathways and diabetic‐related diseases will ultimately result in a better management of these diseases.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc
Subject
Adaptor Proteins, Signal Transducing - genetics
/ canonical Wnt signalling pathway
/ Diabetes
/ Diabetes mellitus (non-insulin dependent)
/ Diabetes Mellitus, Type 2 - genetics
/ Diabetes Mellitus, Type 2 - pathology
/ Disease
/ Genes
/ Humans
/ Kinases
/ Ligands
/ Low Density Lipoprotein Receptor-Related Protein-6 - genetics
/ Lymphoma
/ non‐canonical Wnt signalling pathway
/ Proteins
/ Review
/ Reviews
/ Roles
/ Serine-Arginine Splicing Factors - genetics
/ Wnt Proteins - classification
